期刊文献+

系统生物学技术在药源性肝损伤中应用的研究进展 被引量:3

Research Advances in Drug-Induced Liver Injury Based on Systems Biology Technology
收藏 分享 导出
摘要 目的药源性肝损伤(drug-inducedliver injury,DILI)的临床表现和病理变化较为复杂,传统的临床生化指标不足以全面评价其发病机制,笔者综述近年来基于基因组学、蛋白质组学及代谢组学等系统生物学技术在肝毒性中的研究进展,为药源性肝损伤的预防、诊断、治疗提供依据。方法对近几年国内外采用不同组学技术研究肝损伤相关文献进行分析综述。结果与传统评价方法相比,系统生物学对于发现新型肝脏毒性生物标志物及探讨其形成机制更为全面,且准确度和灵敏度更高。结论基于基因组学、蛋白质组学、代谢组学的系统生物学技术将为肝毒性生物标记物的发掘及肝毒性诊断提供可靠的依据,将在药品肝毒性评价、机制研究及临床诊断等方面发挥重大的作用。 OBJECTIVE To review the development of systems biology technology such as genomics, proteomics and metabonom- ics in hepatotoxicity research and may provide a reference for the prevention, diagnosis, treatment of DILI. METHODS Literatures about different omics in liver injury, which were published in recent years, were summarized and reviewed. RESULTS Compared with traditional methods, systems biology technology shows higher sensitivity and accuracy in finding the liver toxicity biomarkers and comprehensive formation mechanism. CONCLUSION Based on genomics, proteomics and metabonomics, systems biology technolo- gy will provide reliable evidences for the discovery of novel hepatotoxic markers and the diagnosis of hepatotoxicity. Therefore, systems biology technology may play a major role in hepatotoxicity assessment, hepatotoxicity mechanism research and clinical diagnosis in the future.
作者 吴骁 陆益红 汪玉馨 汤道权 樊夏雷 WU Xiao, LU Yi-hong, WANG Yu-xin ,TANG Dao-quan, FAN Xia-lei (1. Department of Pharmaceutical Anal- ysis, Xuzhou Medical College, Xuzhou 221004, China ;2. Jiangsu Institute for Food and Drug Control, Nanjing 210008, China ; 3. China Pharmaceutical University, Nanjing 210009, China)
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第12期1009-1013,共5页 Chinese Pharmaceutical Journal
关键词 药源性肝损伤 系统生物学 基因组学 蛋白质组学 代谢组学 drug-induced liver injury systems biology genomics proteomics metabonomics
作者简介 吴骁,女,硕士研究生研究方向:体内药物分析学及药品安全性研究 通讯作者:樊夏雷,男,博士,主任药师,硕士生导师研究方向:色谱分析及药品安全性研究Tel/Fax:(025)83313672E-mail:fanxialei@sohu.com
  • 相关文献

参考文献48

  • 1SHI Q, HONG H, SENIOR J, et aL Biomarkers for drug-in- duced liver injury [ J]. Expert Rev Gastroenter Hepatol, 2010, 4 (2) :225-234. 被引量:1
  • 2JAESCHKE H, MCGILL M R, RAMACHANDRAN A. Oxidant stress, mitoehondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity [J]. Drug Metab Rev, 2012, 44(1) :88-106. 被引量:1
  • 3DROBNJt Z, WALTON F S, PAUL D S, et al. Metabolism of ar- senic in human liver: The role of membrane transporters [ J ]. Arch Toxicol , 2010, 84(1 ):3-16. 被引量:1
  • 4BEGRICHE K, MASSART J, ROBIN M A, et al. Drug-induced toxicity on mitochondria and lipid metabolism:Mechanistic diver- sity and deleterious consequences for the liver [ J ]. J Hepatol, 2011, 54(4) :773-794. 被引量:1
  • 5ZHANG X, LIU F, CHEN X, et al. Involvement of the immune system in idiosyncratic drug reactions [ J ] Drug Metab Pharm, 2011,26( 1 ) :47-59. 被引量:1
  • 6YUAN L, KAPLOW1TZ N. Mechanisms of drug-induced liver in- jury[J]. Clin Liver Dis , 2013, 17(4) :507-518. 被引量:1
  • 7TUJIOS S, FONTANA R J. Mechanisms of drug-induced liver in- jury: From bedside to bench[J]. Na Rev Gastroenterol Hepatol , 2011, 8(4) :202-211. 被引量:1
  • 8JU C, REILLY T. Role of immune reactions in drug-induced liver injury (DILl) [J]. Drug Metab Rev, 2012, 44( 1 ) :107-115. 被引量:1
  • 9CHALASANI N, BJORNSSON E. Risk factors for idiosyncratic drug-induced liver injury [ J]. Gastroenterology, 2010, 138 ( 7 ) : 2246-2259. 被引量:1
  • 10AMACHER D E. The primary role of hepatic metabolism in idio-syncratic drug-induced liver injury [ J ]. Expert Opin Drug Metab Toxicol , 2012, 8 (3) :335-347. 被引量:1

二级参考文献19

  • 1吴焕淦 ,刘慧荣 ,赵琛 ,张卫 ,吴学飞 ,周爽 ,施茵 ,刘敏 .隔药灸治疗大鼠溃疡性结肠炎差异表达基因研究[J].中国针灸,2005,25(5):359-365. 被引量:15
  • 2顾军,刘作易,张春秀,唐祖明,陆祖宏.细胞芯片的研究进展[J].细胞与分子免疫学杂志,2007,23(3):288-290. 被引量:5
  • 3Espina V,Woodhouse E C,Wulfkuhle J,et al.Protein microarray detection strategies:focus on direct detection technologies. J Immunol Methods,2004,290(12):121-133. 被引量:1
  • 4Dalton R A.Can researchers find recipe for proteins and chips. Nature, 1999,402(6763):718-719. 被引量:1
  • 5Simon R.Applieations of tissue microarray technology.Methods Mol Biol.2010,664:1-16. 被引量:1
  • 6Lu C,Xiao C,Chen C,et al.Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine:distinct molecular signatures indentified by microarray expression profiles in CD4positive T cell.Rheumatol Int,2010,published online. 被引量:1
  • 7Ma T,Tan C,Zhang H,et al.Bridging the gap between traditional Chinese medicine and systems biolog'y:the connection of Cold Syndrome and NEI network.Mol BioSyst,2010,6:613-619. 被引量:1
  • 8Yin L M,Jiang G H,Wang Y,et al.Use of serial analysis of gene expression to reveal the specific regulation of gene expression profile in asthmatic rats treated by acupuncture.Journal of Biomedical Science,2009:16-46. 被引量:1
  • 9Xie Z Q,Liang G,Zhang L,et al.Molecular mechanisms underlying the cholesterol-lowering effect of Ginkgo biloba extract in hepatocytes:a comparative study with lovastatin.Acta Pharmacol Sin,2009,30(9):1262-1275. 被引量:1
  • 10Sze S C,Zhang K Y,Shaw P C,et al.A DNA microarray for differentiation of (Fengdou Shihu) by its 5 S ribosomal DNA intergenic spacer region.Biotechnol Appl Biochem,2008,49(Pt2): 149-154. 被引量:1

共引文献8

同被引文献46

引证文献3

二级引证文献18

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈
新型冠状病毒肺炎防控与诊疗专栏